8th Pharmacovigilance 2015
“Ensuring safer drugs to market by analyzing latest developments
in pharmacovigilance, drug safety and risk management"
I am happy to invite you and your colleagues to be a sponsor / delegate for our upcoming conference. The “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management” at 8th Pharmacovigilance 2015 on 24th & 25th February 2015, Marriott Marble Arch Hotel, London, UK.
Key Themes Discussed at this Summit:
• Update yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
• Developing Pharmacovigilance into high quality management system and its components
• Audit and Inspection: Realistic steps for a fruitful consequence
• EMA PSMF - Assuring compliance and provide standardization
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Developments in Pharmacovigilance, drug safety & risk management to ensure safer drugs to market
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Determining the steps and strategies for enhancing quality in healthcare
• Emerging signal detection data gathering successful tools to highlight emerging risks
• IT solutions for Pharmacovigilance – Learn & Explore
• Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
• GVP Module V and XVI – explaining authority expectations and avoid speculation and differing interpretation of the current guidelines
• Review the use of (PSURs) post-authorisation for safety signals
• ICH-R3 standards - Determining where future challenges could arise
• The developing regulatory framework in advanced and developing markets
• Accelerating new medicine introduction in developing world & overcoming challenges
• Explaining how to use the data sources and observational research for effective safety analysis
• Be part of a major networking opportunity
Key Speakers:
• Michael Richardson, VP International & QPPV EU GPV&E, Bristol Myers Squibb
• Kathy Williams, Lead Pharmacovigilance & Regulatory Excellence, GRAPSQA, AstraZeneca
• William Gregory, Director - Safety & Risk Management, Pfizer (USA)
• Michael Bean, Senior Director, Regulatory Compliance R&D at Janssen, Johnson & Johnson
• Franck Schwartz, Senior Director, Safety & Compliance, Novartis
• Catherine Akers, Regulatory Affairs Manager – EU Policy, Amgen
• Akshaya Nath, Senior Vice President, Global Operations & Business Development, Lambda Therapeutic Research
• John Parkinson, Consultant Expert, Healthcare Data (Former Director CPRD, MHRA)
• Sumit Munjal, Global Director, Pharmacovigilance & EU Region Medical Advisor - Lead Oncology Portfolio, Takeda Pharmaceuticals
• Deborah Layton, Principal Research Fellow, Drug Safety Research Unit (DSRU)
• Brian Edwards, Principal Consultant, Pharmacovigilance & Drug Safety, NDA
• David Jefferys, Sr. VP Regulatory, Eisai Pharmaceuticals
• Barbara Dawson, Vice President - EU QPPV, The Medicines Company
• Steinar Madsen, Medical Director, Norweigen Medicines Agency
• Pipasha Biswas, Director, Symogen
• Veronique Basch, Executive Director, Global Pharmacovigilance, UBC
• Veronica Fjellström, Deputy QPPV, Bluefish Pharmaceuticals
• Fiona Maini, Sr. Manager, Deloitte Consulting
• Gillian P Lennard, Director of Regulatory Affairs, European Regulatory Solutions
Plus Many More...
Key Sponsors:-
Silver Partner : Lambda
Bronze Partner : Adamas
Associate Partner : Bytemindz
Exhibitor : Zigzag
Target Audiance-Industry:-
• Pharmaceutical organisations
• Generic pharmaceutical companies
• Contract research organisations
• Patient recruitment companies
• Government- Department of health
• Non-profit organisations/ Association
• Consultans
Conference Booking Details:
Introductory Offer (3 delegate places for the price of 2):- A huge saving of ÂŁ 800 - (Limited seats left)
Early Discount (13th December 2014 - 16th January 2015):- Conference Delegate Pass (ÂŁ 800 + VAT per delegate)
Standard Registration (17th January 2015):- Conference Delegate Pass (ÂŁ 1100 + VAT per delegate)
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to –
Nisha :- +91 7401150416. Email – nisha@virtueinsight.co.in
We also have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
Should you or any of your colleagues be interested in participating, please let me know and I would be glad assist you accordingly.
“Ensuring safer drugs to market by analyzing latest developments
in pharmacovigilance, drug safety and risk management"
I am happy to invite you and your colleagues to be a sponsor / delegate for our upcoming conference. The “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management” at 8th Pharmacovigilance 2015 on 24th & 25th February 2015, Marriott Marble Arch Hotel, London, UK.
Key Themes Discussed at this Summit:
• Update yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
• Developing Pharmacovigilance into high quality management system and its components
• Audit and Inspection: Realistic steps for a fruitful consequence
• EMA PSMF - Assuring compliance and provide standardization
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Developments in Pharmacovigilance, drug safety & risk management to ensure safer drugs to market
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Determining the steps and strategies for enhancing quality in healthcare
• Emerging signal detection data gathering successful tools to highlight emerging risks
• IT solutions for Pharmacovigilance – Learn & Explore
• Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
• GVP Module V and XVI – explaining authority expectations and avoid speculation and differing interpretation of the current guidelines
• Review the use of (PSURs) post-authorisation for safety signals
• ICH-R3 standards - Determining where future challenges could arise
• The developing regulatory framework in advanced and developing markets
• Accelerating new medicine introduction in developing world & overcoming challenges
• Explaining how to use the data sources and observational research for effective safety analysis
• Be part of a major networking opportunity
Key Speakers:
• Michael Richardson, VP International & QPPV EU GPV&E, Bristol Myers Squibb
• Kathy Williams, Lead Pharmacovigilance & Regulatory Excellence, GRAPSQA, AstraZeneca
• William Gregory, Director - Safety & Risk Management, Pfizer (USA)
• Michael Bean, Senior Director, Regulatory Compliance R&D at Janssen, Johnson & Johnson
• Franck Schwartz, Senior Director, Safety & Compliance, Novartis
• Catherine Akers, Regulatory Affairs Manager – EU Policy, Amgen
• Akshaya Nath, Senior Vice President, Global Operations & Business Development, Lambda Therapeutic Research
• John Parkinson, Consultant Expert, Healthcare Data (Former Director CPRD, MHRA)
• Sumit Munjal, Global Director, Pharmacovigilance & EU Region Medical Advisor - Lead Oncology Portfolio, Takeda Pharmaceuticals
• Deborah Layton, Principal Research Fellow, Drug Safety Research Unit (DSRU)
• Brian Edwards, Principal Consultant, Pharmacovigilance & Drug Safety, NDA
• David Jefferys, Sr. VP Regulatory, Eisai Pharmaceuticals
• Barbara Dawson, Vice President - EU QPPV, The Medicines Company
• Steinar Madsen, Medical Director, Norweigen Medicines Agency
• Pipasha Biswas, Director, Symogen
• Veronique Basch, Executive Director, Global Pharmacovigilance, UBC
• Veronica Fjellström, Deputy QPPV, Bluefish Pharmaceuticals
• Fiona Maini, Sr. Manager, Deloitte Consulting
• Gillian P Lennard, Director of Regulatory Affairs, European Regulatory Solutions
Plus Many More...
Key Sponsors:-
Silver Partner : Lambda
Bronze Partner : Adamas
Associate Partner : Bytemindz
Exhibitor : Zigzag
Target Audiance-Industry:-
• Pharmaceutical organisations
• Generic pharmaceutical companies
• Contract research organisations
• Patient recruitment companies
• Government- Department of health
• Non-profit organisations/ Association
• Consultans
Conference Booking Details:
Introductory Offer (3 delegate places for the price of 2):- A huge saving of ÂŁ 800 - (Limited seats left)
Early Discount (13th December 2014 - 16th January 2015):- Conference Delegate Pass (ÂŁ 800 + VAT per delegate)
Standard Registration (17th January 2015):- Conference Delegate Pass (ÂŁ 1100 + VAT per delegate)
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to –
Nisha :- +91 7401150416. Email – nisha@virtueinsight.co.in
We also have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
Should you or any of your colleagues be interested in participating, please let me know and I would be glad assist you accordingly.
